Speech-Language Pathologists in Carlisle, PA Accepting Medicare

37 Speech-Language Pathologists found. Showing 21 - 37

Eva B Gustafson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 42 S Pitt St, Carlisle, PA 17013 Phone: 202-751-5099

Grow & Tell Speech-language Pathology, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 904 Dunbar Rd, Carlisle, PA 17013 Phone: 717-512-2841    Fax: 717-297-8380

Meghan Mari Pandya, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 804 Belvedere St, Carlisle, PA 17013 Phone: 717-385-2429

Mrs. Madison Jean Smith, M.S. Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 770 S Hanover St, Carlisle, PA 17013 Phone: 717-249-1363

Brooke August, MS - SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 904 Dunbar Rd, Carlisle, PA 17013 Phone: 717-512-2841

Ms. Amy H. Hempt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29 Old Stonehouse Rd S, Carlisle, PA 17015 Phone: 717-766-5721

Ms. Emily Kapp, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 940 Walnut Bottom Rd, Carlisle, PA 17015 Phone: 717-249-0085

Megan C Kane-mangol, M.A.,CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1301 Sadler Dr, Carlisle, PA 17013 Phone: 717-448-8575

Courtney Holtzapple Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Claremont Rd, Carlisle, PA 17013 Phone: 717-243-2031

Orit Porter Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 700 Walnut Bottom Rd, Carlisle, PA 17013 Phone: 717-960-7720

Grow & Tell Speech-language Pathology, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 904 Dunbar Rd, Carlisle, PA 17013 Phone: 717-512-2841    Fax: 717-297-8380

Anthony Bruce Spittler, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 801 N Hanover St, Carlisle, PA 17013 Phone: 717-249-5322

Whitney Shay Black, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 804 Belvedere St, Carlisle, PA 17013 Phone: 717-512-2841

Elizabeth S Frantz, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 220 Wilson St, Suite 100, Carlisle, PA 17013 Phone: 717-245-5600

Molly Stover Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 804 Belvedere St, Carlisle, PA 17013 Phone: 717-512-2841

Jessica E Over, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 904 Dunbar Rd, Carlisle, PA 17013 Phone: 717-512-2841    Fax: 717-297-8380

Alexandra J Zara Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Longsdorf Way, Carlisle, PA 17015 Phone: 570-592-4185

News Archive

Actavis resolves patent litigation related to generic version of INTUNIV for treatment of ADHD

Actavis, Inc., a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with Shire plc resolving outstanding patent litigation related to Actavis' generic version of INTUNIV® (guanfacine hydrochloride) for the treatment of Attention Deficit Hyperactivity Disorder.

Quiet and shy pupils tend to under achieve

New research from the University of Stavanger shows that quiet and shy pupils in junior high schools in Norway achieve below their active classmates in oral, practical and esthetic subjects.

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2

Scientists at the University of Wisconsin reveals that the genetic variants of human angiotensin 2 (ACE2) receptors can have altered recognition by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. The study is currently available on the bioRxiv* preprint server.

UCB, Synosia Therapeutics announce new strategic partnership in neurology

UCB and Synosia Therapeutics announced today a new strategic partnership in neurology. Synosia has granted UCB a license for exclusive, worldwide rights to the development compound SYN-115 and rights to a second compound, SYN-118, for non-orphan indications. Both are in Phase II clinical development for the treatment of Parkinson's disease.

CB&I signs definitive agreement with H2Gen Innovations to acquire PSA technology

CB&I (NYSE:CBI) announced today that it has entered into a definitive agreement with H2Gen Innovations, Inc., to acquire the Mars modularized Pressure Swing Adsorption (PSA) technology.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)